IMPAC Medical Systems and The Mattson Jack Group Announce Expanded Agreement
15 May 2005
IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, and The Mattson Jack Group (MJG), a world leader in healthcare consulting services, today announce an expanded licensing agreement that will grant MJG access to IMPAC's oncology-specific electronic medical record (EMR) for point of care data, in addition to data from its National Oncology DataBase(TM) (NODB), to be used in MJG's Patient Metrics module of Cancer!MPact.
Like the NODB, the EMR data is provided from participating IMPAC customers. The new de-identified EMR-derived dataset has the potential for adding a unique and expanded body of information from hundreds of thousands of cancer cases in near real time. When added to data from the more than 2 million NODB cancer registry derived cases, it greatly augments the breadth and depth of the resultant information.
Bill Mattson, Co-chairman and Co-CEO of the Mattson Jack Group, said, "We are pleased to expand our ongoing relationship with IMPAC. This agreement will facilitate research and analyses on geographical trends. The longitudinal EMR point of care data will be invaluable in providing more timely information on actual treatment practice at the point of care."
"IMPAC and The Mattson Jack Group have a long history of working together. We are pleased to expand our agreement so that retrospective analysis and research into treatment practices and outcomes can be taken to the next level," said Joseph K. Jachinowski, IMPAC president and CEO.
Demonstrations of IMPAC's oncology-specific EMR will be available at IMPAC's booth # 2872 during the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, May 14-16, 2005.
For more information, please contact:
Julie DeSantis, Public Relations Manager
IMPAC Medical Systems, Inc.
Tel: 650-623-8883, e-mail: jdesantis@impac.com
Investor Enquiries:
International: Peter Ejemyr, Group VP Corporate Communications,
Elekta AB
Tel: +46 733 611 000, e-mail: peter.ejemyr@elekta.com
United States: Lars Jonsteg, VP Investor Relations North America,
Elekta Inc.
Tel: +46 708-783 735, e-mail: lars.jonsteg@elekta.com
About IMPAC Medical Systems
IMPAC Medical Systems, Inc., a company in the Elekta Group, provides healthcare IT solutions that streamline clinical and business operations across the spectrum of cancer care. IMPAC's open integration to multiple healthcare data and imaging systems offers oncology-specific patient charting and practice management, as well as best-of-breed systems for anatomic pathology, clinical laboratory, and cancer registry. With products that range from diagnosis and treatment through long-term follow-up, IMPAC provides a comprehensive oncology management solution that helps improve overall communication, process efficiency, and quality patient care. For more information about IMPAC's products or services, please call 888-GO-IMPAC or visit www.impac.com.
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
With approx. 1700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb. For more information about Elekta's products or services, please visit www.elekta.com.
About the Mattson Jack Group
Formed in 1986, MJG focuses its talent in three areas of core competency: Business Analytics, Brand Optimization and Corporate Development Services in the pharmaceutical and biotech markets. Its ongoing mission is to "Accelerate Client Growth through advanced analysis, planning, decision support, and implementation." MJG consultants have expertise in pricing and reimbursement, custom epidemiology, technology assessment, business and strategic plan development, due-diligence and licensing support, market modeling and forecasting, and primary market research. The Mattson Jack Group is a member of the Kantar Division of WPP Company, a $6.5 billion global communications services firm. For more information, please visit www.mattsonjack.com.
--------------------------------------------------------------------------------
Source: IMPAC Medical Systems, Inc.
Source: PR Newswire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|
